With a simple message a single-loop animation, this banner ad successfully delivers the approval message to neurologists.
Ocrevus Now Approved Banner Ads on MedPageToday
![](https://oncedailypharma.com/wp-content/uploads/2017/05/ocrevus-now-approven-banner.png)
Brand: Ocrevus (ocrelizumab), Intravenous Infusion
Parent Company: Genentech
Drug Type: Prescription
Drug Category: Neurology
Campaign: now-approved
Targeting: HCPs
Patient Website: https://www.ocrevus.com/patient.html
HCP Website: https://www.ocrevus.com/hcp.html